These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 35740529)

  • 1. Targeting Breast Cancer-Derived Stem Cells by Dietary Phytochemicals: A Strategy for Cancer Prevention and Treatment.
    Prajapati KS; Gupta S; Kumar S
    Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signaling pathways governing the maintenance of breast cancer stem cells and their therapeutic implications.
    Ordaz-Ramos A; Tellez-Jimenez O; Vazquez-Santillan K
    Front Cell Dev Biol; 2023; 11():1221175. PubMed ID: 37492224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast Cancer Stem Cells: Signaling Pathways, Cellular Interactions, and Therapeutic Implications.
    Wang L; Jin Z; Master RP; Maharjan CK; Carelock ME; Reccoppa TBA; Kim MC; Kolb R; Zhang W
    Cancers (Basel); 2022 Jul; 14(13):. PubMed ID: 35805056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Therapeutics Against Breast Cancer Stem Cells by Targeting Surface Markers and Signaling Pathways.
    Das PK; Rakib MA; Khanam JA; Pillai S; Islam F
    Curr Stem Cell Res Ther; 2019; 14(8):669-682. PubMed ID: 31808385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic Pathways of Malignancy in Breast Cancer Stem Cells.
    Yousefnia S; Seyed Forootan F; Seyed Forootan S; Nasr Esfahani MH; Gure AO; Ghaedi K
    Front Oncol; 2020; 10():452. PubMed ID: 32426267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium.
    Feng ZM; Qiu J; Chen XW; Liao RX; Liao XY; Zhang LP; Chen X; Li Y; Chen ZT; Sun JG
    BMC Cancer; 2015 Sep; 15():645. PubMed ID: 26400441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression and significance of insulin-like growth factor-1 receptor and its pathway on breast cancer stem/progenitors.
    Chang WW; Lin RJ; Yu J; Chang WY; Fu CH; Lai A; Yu JC; Yu AL
    Breast Cancer Res; 2013 May; 15(3):R39. PubMed ID: 23663564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WNT pathway inhibitor pyrvinium pamoate inhibits the self-renewal and metastasis of breast cancer stem cells.
    Xu L; Zhang L; Hu C; Liang S; Fei X; Yan N; Zhang Y; Zhang F
    Int J Oncol; 2016 Mar; 48(3):1175-86. PubMed ID: 26781188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role, molecular mechanism and the potential target of breast cancer stem cells in breast cancer development.
    Zhang T; Zhou H; Wang K; Wang X; Wang M; Zhao W; Xi X; Li Y; Cai M; Zhao W; Xu Y; Shao R
    Biomed Pharmacother; 2022 Mar; 147():112616. PubMed ID: 35008001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel lncRNA ROPM-mediated lipid metabolism governs breast cancer stem cell properties.
    Liu S; Sun Y; Hou Y; Yang L; Wan X; Qin Y; Liu Y; Wang R; Zhu P; Teng Y; Liu M
    J Hematol Oncol; 2021 Oct; 14(1):178. PubMed ID: 34715882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects and mechanisms of SLC34A2 on maintaining stem cell-like phenotypes in CD147
    Lv Y; Wang T; Fan J; Zhang Z; Zhang J; Xu C; Li Y; Zhao G; He C; Meng H; Yang H; Wang Z; Liu J; Chen J; Wang L
    Tumour Biol; 2017 Apr; 39(4):1010428317695927. PubMed ID: 28381172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy.
    Pham PV; Phan NL; Nguyen NT; Truong NH; Duong TT; Le DV; Truong KD; Phan NK
    J Transl Med; 2011 Dec; 9():209. PubMed ID: 22152097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sinomenine hydrochloride suppresses the stemness of breast cancer stem cells by inhibiting Wnt signaling pathway through down-regulation of WNT10B.
    Li X; Chen W; Huang L; Zhu M; Zhang H; Si Y; Li H; Luo Q; Yu B
    Pharmacol Res; 2022 May; 179():106222. PubMed ID: 35413424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel and Alternative Targets Against Breast Cancer Stemness to Combat Chemoresistance.
    Sridharan S; Howard CM; Tilley AMC; Subramaniyan B; Tiwari AK; Ruch RJ; Raman D
    Front Oncol; 2019; 9():1003. PubMed ID: 31681564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The "Big Five" Phytochemicals Targeting Cancer Stem Cells: Curcumin, EGCG, Sulforaphane, Resveratrol and Genistein.
    Naujokat C; McKee DL
    Curr Med Chem; 2021; 28(22):4321-4342. PubMed ID: 32107991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ZGRF1 Is Associated with Poor Prognosis in Triple-Negative Breast Cancer and Promotes Cancer Stemness Based on Bioinformatics.
    Ge W; Jiang M; Zhang F; Ma Y; Wang H; Xu Y
    Onco Targets Ther; 2020; 13():2843-2854. PubMed ID: 32308418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary phytochemicals in colorectal cancer prevention and treatment: A focus on the molecular mechanisms involved.
    Afrin S; Giampieri F; Gasparrini M; Forbes-Hernández TY; Cianciosi D; Reboredo-Rodriguez P; Zhang J; Manna PP; Daglia M; Atanasov AG; Battino M
    Biotechnol Adv; 2020; 38():107322. PubMed ID: 30476540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting cancer stem cells in breast cancer: potential anticancer properties of 6-shogaol and pterostilbene.
    Wu CH; Hong BH; Ho CT; Yen GC
    J Agric Food Chem; 2015 Mar; 63(9):2432-41. PubMed ID: 25686711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer stem cells, heterogeneity, targeting therapies and therapeutic implications.
    Zeng X; Liu C; Yao J; Wan H; Wan G; Li Y; Chen N
    Pharmacol Res; 2021 Jan; 163():105320. PubMed ID: 33271295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortalin maintains breast cancer stem cells stemness via activation of Wnt/GSK3β/β-catenin signaling pathway.
    Wei B; Cao J; Tian JH; Yu CY; Huang Q; Yu JJ; Ma R; Wang J; Xu F; Wang LB
    Am J Cancer Res; 2021; 11(6):2696-2716. PubMed ID: 34249423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.